Brief: Eis Eczacibasi Ilac Says Unit Eip Eczacibasi Executes License And Commercialization Agreement With Pharma Mar For Marketing And Sales Rights Of Zepzelca Medicine
Dec 22 (Reuters) - EIS ECZACIBASI ILAC ECILC.IS :
* REPORTED ON TUESDAY OUR UNIT EIP ECZACIBASI ILAC PAZARLAMA
HAS
EXECUTED LICENSE AND COMMERCIALIZATION AGREEMENT WITH
SPAIN-BASED PHARMA MAR S.A. FOR THE MARKETING AND SALES RIGHTS
OF THE MEDICINE BEARING THE "ZEPZELCA" TRADEMARK IN TURKEY
Source text for Eikon: urn:newsml:reuters.com:*:nIKA3HlbSV
Further company coverage: ECILC.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
See all newsMSCI to downgrade Astor Enerji and Sabanci Holding to Turkey Global Small Cap Index, remove 18 Turkish stocks
Brief: Eis Eczacibasi Q3 Net Result Turns To Loss Of 542.1 Mln Lira YoY
Brief: Eis Eczacibasi Ilac Says It Was Notified Of Construction Permits Obtained For 1,015 Units In Istanbul
Brief: Eis Eczacibasi Q2 Net Result Turns To Loss Of 760.5 Mln Lira YoY
Brief: Eis Eczacibasi Ilac Says It Completes Sale Of All Shares In Sanipak Saglikli Yasam Urunleri As Of July 31